Archived:
https://web.archive.org/web/20170130193016/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-kharkiv-eng.pdf
https://web.archive.org/web/20210511164310/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-luhansk-eng.pdf
https://web.archive.org/web/20170221125752/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-dnipropetrovsk-eng.pdf
https://web.archive.org/web/20210506053014/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-vinnitsa-eng.pdf
https://web.archive.org/web/20170221125752/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-dnipropetrovsk-eng.pdf
https://web.archive.org/web/20170207122550/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-kherson-fact-sheet-eng.pdf
https://web.archive.org/web/20170223011502/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-ternopil-fact-sheet-eng.pdf
https://web.archive.org/web/20170208032526/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-zakarpatska-fact-s
@wokeinteldrops
https://web.archive.org/web/20170130193016/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-kharkiv-eng.pdf
https://web.archive.org/web/20210511164310/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-luhansk-eng.pdf
https://web.archive.org/web/20170221125752/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-dnipropetrovsk-eng.pdf
https://web.archive.org/web/20210506053014/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-vinnitsa-eng.pdf
https://web.archive.org/web/20170221125752/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-dnipropetrovsk-eng.pdf
https://web.archive.org/web/20170207122550/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-kherson-fact-sheet-eng.pdf
https://web.archive.org/web/20170223011502/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-ternopil-fact-sheet-eng.pdf
https://web.archive.org/web/20170208032526/https://photos.state.gov/libraries/ukraine/895/pdf/dtro-zakarpatska-fact-s
@wokeinteldrops
Yes, the same Black & Veatch that project manages US Gov underground facilities
https://www.bv.com/projects/btric-ukraine
https://www.bv.com/projects/btric-ukraine
Bv
BTRIC Ukraine
The Defense Threat Reduction Agency (DTRA) competitively awarded Black & Veatch Special Projects Corp. (Black & Veatch) one of its Biological Threat Reduction Integrating Contracts (BTRIC) in 2008.
MECHNIKOV UKRAINIAN ANTI-PLAGUE RESEARCH INSTITUTE
Research Institute of the Ministry of Health of Ukraine, a research institution in Ukraine on epidemiology, microbiology, epizootology of especially dangerous infections, biological safety and biological security.
The Department of Especially Dangerous Bacteria and Virus Research had/has the following laboratories:
• Laboratory of epidemiology
• Laboratory of especially dangerous virus infections
• Laboratory of the ecology of especially dangerous strains
• Laboratory of ecology of carriers and vectors of especially dangerous strains
• Laboratory of slow infections (prions) and AIDS
The Institute receives funding from organizations including the SOROS Foundation and The University of London. The Institute is included in the list of possible International Cooperative Centers in creating the Global Network for Monitoring and Control over biological pathogenic unit agents.
(Source)
@wokeinteldrops
Research Institute of the Ministry of Health of Ukraine, a research institution in Ukraine on epidemiology, microbiology, epizootology of especially dangerous infections, biological safety and biological security.
The Department of Especially Dangerous Bacteria and Virus Research had/has the following laboratories:
• Laboratory of epidemiology
• Laboratory of especially dangerous virus infections
• Laboratory of the ecology of especially dangerous strains
• Laboratory of ecology of carriers and vectors of especially dangerous strains
• Laboratory of slow infections (prions) and AIDS
The Institute receives funding from organizations including the SOROS Foundation and The University of London. The Institute is included in the list of possible International Cooperative Centers in creating the Global Network for Monitoring and Control over biological pathogenic unit agents.
(Source)
@wokeinteldrops
Media is too big
VIEW IN TELEGRAM
RULES OF ENGAGEMENT:
This is an ACTIVE OSINT FEED. Actionable Intelligence, Analysis, Training & Disclosure Research. Relevant MemeticOps posts welcome. Nothing obscene. ANALYSIS & DISCLOSURE RESEARCH is above board and public — especially citing sources and researching background. We use a bot to track 3 WARNINGS and admin decision is final.
@wokeinteldrops
@wokeintelchat
@EXOINTEL
This is an ACTIVE OSINT FEED. Actionable Intelligence, Analysis, Training & Disclosure Research. Relevant MemeticOps posts welcome. Nothing obscene. ANALYSIS & DISCLOSURE RESEARCH is above board and public — especially citing sources and researching background. We use a bot to track 3 WARNINGS and admin decision is final.
@wokeinteldrops
@wokeintelchat
@EXOINTEL
AgendaMonger YouTube is hiring for a “Disinformation Investigation Analyst” and it ended up on an OSINT job posting board.
https://www.osint-jobs.com/
@wokeinteldrops
https://www.osint-jobs.com/
@wokeinteldrops
Project DEFUSE Proposal
DARPA & EcoHealth (2018): Defusing the Threat of Bat-borne Coronaviruses
(Full Proposal)
@wokeinteldrops
DARPA & EcoHealth (2018): Defusing the Threat of Bat-borne Coronaviruses
(Full Proposal)
@wokeinteldrops
5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021
— Prepred by Pfizer
APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
— Photos
“5. SUMMARY AND CONCLUSION
Review of the available data for this cumulative PM experience, confirms a favorable benefit: risk balance for BNT162b2.
Pfizer will continue routine pharmacovigilance activities on behalf of BioNTech according to the Pharmacovigilance Agreement in place, in order to assure patient safety and will inform the Agency if an evaluation of the safety data yields significant new information for BNT162b2.”
(Document)
@wokeinteldrops
— Prepred by Pfizer
APPENDIX 1. LIST OF ADVERSE EVENTS OF SPECIAL INTEREST
— Photos
“5. SUMMARY AND CONCLUSION
Review of the available data for this cumulative PM experience, confirms a favorable benefit: risk balance for BNT162b2.
Pfizer will continue routine pharmacovigilance activities on behalf of BioNTech according to the Pharmacovigilance Agreement in place, in order to assure patient safety and will inform the Agency if an evaluation of the safety data yields significant new information for BNT162b2.”
(Document)
@wokeinteldrops